CGRP antagonist compounds
US12344621B2 · kind B2 · utility
0Cited by
0References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 12, 2020 |
| Grant date | Jul 1, 2025 |
| Priority date | — |
| Expiry date | Jun 4, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/22
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The disclosures herein relate to novel compounds of Formula (1); and salts thereof, wherein A1, A2, Q, X, R1, R2 and R3 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with CGRP receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.